(最終更新日:2026-06-18 13:54:04)
  ナカヤマ タカユキ   NAKAYAMA Takayuki
  中山 貴之
   所属   医学部 医学科(東京女子医科大学病院)  泌尿器科学講座 泌尿器科学分野
   職種   助教
■ 学術雑誌
1. 原著  Real-world outcomes of third-line systemic therapy after immune checkpoint inhibitor combinations and subsequent VEGFR-TKIs in advanced renal cell carcinoma. 2026/06/05
2. 原著  Non-clear cell renal cell carcinoma has an immune-cold phenotype that affects response to immune checkpoint inhibitors. 2026/05/04
3. 原著  Impact of first-line dual immuno-oncology combination therapy versus immuno-oncology plus tyrosine kinase inhibitor on outcomes of second-line VEGFR-TKI in advanced RCC: a real-world multi-institutional analysis. 2026/03
4. 原著  Impact of starting dose of tyrosine kinase inhibitors on outcomes following combination therapy of immune checkpoint inhibitors with tyrosine kinase inhibitors for previously untreated advanced renal cell carcinoma. 2026/01
5. 原著  Comparison of real-world outcomes between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib combination therapies for previously untreated advanced renal cell carcinoma. 2025/10
全件表示(14件)
■ 学会発表
1. 腎細胞癌に対する術後補助療法としてもペムブロリズマブ治療の安全性の検討 (口頭,一般) 2026/04/24
2. Experience of adjuvant pembrolizumab in patients with renal cell carcinoma: An initial report using short-term follow-up data. (ポスター掲示,一般) 2026/04/23
3. 腎細胞がんに対するfirst-line IO-TKI治療の3年観察期間リアルワールドデータ (口頭,一般) 2026/04/23
4. 腎細胞癌の腫瘍免疫微小環境におけるB細胞およびNK細胞浸潤の予後的意義 (ポスター掲示,一般) 2026/04/23
5. 婦人科腹腔鏡手術中に起きた膀胱膣ろうを腹腔鏡下o‘conor法アプローチで修復した一例 (口頭,一般) 2026/02/12
全件表示(47件)